Opendata, web and dolomites

ILO SIGNED

Innovative dual cycle tracking system for contraception and conception on a single device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ILO project word cloud

Explore the words cloud of the ILO project. It provides you a very rough idea of what is the project "ILO" about.

subsequently    track    exhaled    thanks    subjective    pregnant    opportunity    wish    monitoring    natural    window    variables    proven    health    sell    conceiving    valued    algorithms    fulfils    approached    handheld    levels    2016    million    billion    irregular    core    combination    women    child    progression    700    golden    none    cutting    temperature    invasive    rely    ilo    cycle    expertise    amount    stage    carbomed    profits    staff    bleeding    lack    23    tool    market    contraceptive    contraception    business    scientifically    periods    precise    tracking    accurate    relying    conveys    time    chances    commercialization    influencing    strive    back    count    seamlessly    device    predicts    edge    fairly    predicting    reliably    first    self    app    menstrual    overcome    accuracy    measuring    length    cumulative    hence    fertile    body    bespoke    air    facts    initially    17    fashioned    innovative    stress    criteria    manner    39    500    usually    reaching    limitations    co2    period    ovulation    units    dual    2023    180   

Project "ILO" data sheet

The following table provides information about the project.

Coordinator
CARBOMED MEDICAL SOLUTIONS GMBH & CO KG 

Organization address
address: NEUE STIFTINGTALSTRASSE 2/5 OG
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.iloveovulation.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARBOMED MEDICAL SOLUTIONS GMBH & CO KG AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

Women usually track their menstrual cycle for three main reasons: As a natural contraceptive tool, to increase the chances of conceiving or for health-related reasons. However, monitoring every stage of the cycle in an accurate manner has proven challenging, due to the many variables influencing its progression (e.g. irregular periods, stress, etc.). Currently, there are two main approached to cycle tracking: Cycle tracking devices (which represent the old-fashioned approach, fairly reliable but require self-assessment and expertise to get accuracy), and “cutting edge” app-based cycle tracking methods (which are user-friendly, but rely in subjective facts related to the period - e.g. length or amount of bleeding-, traditional measurements -e.g. core body temperature- and algorithms, and lack accuracy. Hence, none of these approaches fulfils the “golden” criteria of being reliable, precise, simple and non-invasive. At Carbomed, we strive to overcome the limitations of both approaches thanks to our innovative ILO system, the seamlessly combination of a handheld device and an app, that reliably predicts the time of ovulation by relying on a scientifically-based method: Measuring the CO2 levels from exhaled air. ILO conveys the best features from both approaches, being accurate, simple and non-invasive while providing a user-friendly experience thanks to our bespoke app. ILO can be used as a dual cycle tracking device predicting the most fertile window, as a natural contraceptive method, but also as a tracking device for those who want to get pregnant. For Carbomed, ILO represents a large business opportunity, aimed initially at the child wish market and subsequently (and most importantly) at the contraception market valued at €17.6 billion back in 2016. In this way, we expect to sell 180,500 ILO units in the first three years of commercialization, reaching cumulative profits of €23.39 million by 2023. To reach this goal, we will increase our staff count by 700%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ILO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ILO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More